Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Chain termination prokaryotic

Acts as analog of aminoacyl-tRNA and causes premature chain termination in both prokaryotes and eukaryotes. [Pg.345]

Puromycin Causes premature chain termination by acting as an analog of aminoacyl-tRNA (prokaryotes and eukaryotes)... [Pg.1237]

Synthesis of all polypeptide chains In prokaryotic and eukaryotic cells begins with the amino acid methionine. In most mRNAs, the start (initiator) codon specifying this amino-terminal methionine is AUG. In a few bacterial mRNAs, GUG is used as the initiator codon, and CUG occasionally is used as an initiator codon for methionine in eukaryotes. The three codons UAA, UGA, and UAG do not specify amino acids but constitute stop (termination) codons that mark the carboxyl terminus of polypeptide chains in almost all cells. The sequence of codons that runs from a specific... [Pg.120]

The protein synthesis inhibitors tetracycline, chloramphenicol, and streptomycin all block bacterial protein synthesis. Several eukaryotic translational inhibitors have also been found and they include diphtheria toxin, ricin, and cycloheximide. Puromycin causes premature chain termination in both prokaryotes and eukaryotes by functioning as an aminoacyl tRNA analog. [Pg.759]

Elongation and termination - Eukaryotic chain termination, in contrast to prokaryotic termination, requires only one protein factor- eRF (Table 28.7), which can recognize all three stop codons (UAA, UAG, and UGA). Otherwise the mechanisms are very similar. [Pg.2052]

The details of the chain of events in translation differ somewhat in prokaryotes and eukaryotes. Like DNA and RNA synthesis, this process has been more thoroughly studied in prokaryotes. We shall use Escherichia coli as our principal example, because aU aspects of protein synthesis have been most extensively studied in this bacterium. As was the case with replication and transcription, translation can be divided into stages—chain initiation, chain elongation, and chain termination. [Pg.340]

Eukaryotic chain elongation is similar to the prokaryotic counterpart. With chain termination, there is only one release factor that binds to all three stop codons. [Pg.354]

Chain termination. Two types of transcription termination operate in prokaryotes ... [Pg.463]

Diagrammatic representation of translation on prokaryotic ribosomes. The elongation cycle starts by interaction of the 70S initiation complex with fMet- tRNA EFTu GTP. In all subsequent rounds of the cycle, fMet-tRNArEFT tGTP interacts with the mRNA ribosome complex carrying the growing polypeptide chain. Termination occurs when n amino acids have been incorporated, where n represents the number of codons between the initiation codon AUG and the termination codon (in this example UAA). [Pg.560]

The fundamental process is identical in prokaryotes and eukaryotes, in that an RNA polymerase complex binds to the promoter and initiates transcription at a start site downstream to the promoter. De novo initiation of an RNA chain occurs with a purine nucleotide and creation of a transcription bubble with the open complex. The transcription complex can slide back along the nascent chain and en-donucleolytically cleave off the 3 segment, then moves forward along the DNA template chain termination occurs at specific regions in the genes. [Pg.133]

Another factor that characterizes molybdenum and tungsten enzymes is that instead of using the metal itself, directly coordinated to amino acid side-chains of the protein, an unusual pterin cofactor, Moco, is involved in both molybdenum- and tungsten-containing enzymes. The cofactor (pyranopterin-dithiolate) coordinates the metal ion via a dithiolate side-chain (Figure 17.2). In eukaryotes, the pterin side-chain has a terminal phosphate group, whereas in prokaryotes, the cofactor (R in Figure 17.2) is often a dinucleotide. [Pg.280]

Puromycin inhibits both prokaryotic and eukaryotic translation by binding to the A site. Peptidyl transferase attaches the peptide to puromycin, and the peptide with puromycin attached at the C-terminus is released, prematurely terminating chain growth. [Pg.54]

Abbreviations aa-tRNA Amino-acyl tRNA eLF Eukaryotic translation initiation factor IF Prokaryotic translation initiation factor eEF Eukaryotic translation elongation factor EF Prokaryotic translation elongation factor eRF Eukaryotic translation termination factor (release factor) RF Prokaryotic translation release factor RRF Ribosome recycling factor Rps Protein of the prokaryotic small ribosomal subunit Rpl Protein of the eukaryotic large ribosomal subunit S Protein of the prokaryotic small ribosomal subunit L Protein of the prokaryotic large ribosomal subunit PTC Peptidyl transferase center RNC Ribosome-nascent chain-mRNA complex ram Ribosomal ambiguity mutation RAC Ribosome-associated complex NMD Nonsense-mediated mRNA decay... [Pg.1]

The pathway of protein synthesis translates the three-letter alphabet of nucleotide sequences on mRNA into the twenty-letter alphabet of amino acids that constitute proteins. The mRNA is translated from its 5 -end to its 3 -end, producing a protein synthesized from its amino-terminal end to its carboxyl-terminal end. Prokaryotic mRNAs often have several coding regions, that is, they are polycistronic (see p. 420). Each coding region has its own initiation codon and produces a separate species of polypeptide. In contrast, each eukaryotic mRNA codes for only one polypeptide chain, that is, it is monocistronic. The process of translation is divided into three separate steps initiation, elongation, and termination. The polypeptide chains produced may be modified by posttranslational modification. Eukaryotic protein synthesis resembles that of prokaryotes in most details. [Note Individual differences are mentioned in the text.]... [Pg.435]

Be able to describe the mechanism for peptide chain initiation, elongation, and termination in prokaryotes and eukaryotes on the ribosome. [Pg.329]

Table 29.4). For example, the antibioticpuromycin inhibits protein synthesis by causing nascent prokaryotic polypeptide chains to be released before their synthesis is completed. Puromycin is an analog of the terminal aminoacyl-adenosine part of aminoacyl-tRNA (Figure 29.34). [Pg.1235]


See other pages where Chain termination prokaryotic is mentioned: [Pg.221]    [Pg.358]    [Pg.135]    [Pg.186]    [Pg.723]    [Pg.40]    [Pg.168]    [Pg.254]    [Pg.682]    [Pg.241]    [Pg.2]    [Pg.442]    [Pg.1630]    [Pg.1700]    [Pg.409]    [Pg.185]    [Pg.216]    [Pg.42]    [Pg.402]    [Pg.322]    [Pg.329]    [Pg.122]    [Pg.73]    [Pg.565]    [Pg.832]    [Pg.840]    [Pg.884]    [Pg.598]    [Pg.17]    [Pg.159]    [Pg.125]    [Pg.425]   
See also in sourсe #XX -- [ Pg.345 ]




SEARCH



Chain termination

Chain terminators

Prokaryotes

Prokaryotic

Prokaryots

Terminal chains

© 2024 chempedia.info